Your browser doesn't support javascript.
loading
Variations in glycated haemoglobin with age among individuals with normal glucose tolerance: Implications for diagnosis and treatment-Results from the ICMR-INDIAB population-based study (INDIAB-12).
Deepa, Mohan; Anjana, Ranjit Mohan; Unnikrishnan, Ranjit; Pradeepa, Rajendra; Das, Ashok Kumar; Madhu, Sri Venkata; Rao, Paturi Vishnupriya; Joshi, Shashank; Saboo, Banshi; Kumar, Ajay; Bhansali, Anil; Gupta, Arvind; Bajaj, Sarita; Elangovan, Nirmal; Venkatesan, Ulagamathesan; Subashini, Radhakrishnan; Kaur, Tanvir; Dhaliwal, R S; Tandon, Nikhil; Mohan, Viswanathan.
Afiliação
  • Deepa M; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India.
  • Anjana RM; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India.
  • Unnikrishnan R; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India.
  • Pradeepa R; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India.
  • Das AK; Pondicherry Institute of Medical Sciences, Puducherry, India.
  • Madhu SV; University College of Medical Sciences and GTB Hospital, Delhi, New Delhi, India.
  • Rao PV; Nizam's Institute of Medical sciences, Hyderabad, Andhra Pradesh, India.
  • Joshi S; Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India.
  • Saboo B; Dia Care-Diabetes Care and Hormone Clinic, Ahmedabad, Gujarat, India.
  • Kumar A; Diabetes Care and Research Centre, Patna, Bihar, India.
  • Bhansali A; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Gupta A; Jaipur Diabetes Research Centre, Jaipur, India.
  • Bajaj S; Moti Lal Nehru Medical College, Allahabad, India.
  • Elangovan N; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India.
  • Venkatesan U; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India.
  • Subashini R; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India.
  • Kaur T; Indian Council of Medical Research, Delhi, New Delh, India.
  • Dhaliwal RS; Indian Council of Medical Research, Delhi, New Delh, India.
  • Tandon N; All India Institute of Medical Sciences, Delhi, New Delhi, India.
  • Mohan V; Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Centre for Advanced Research On Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, India. drmohans@diabetes.ind.in.
Acta Diabetol ; 59(2): 225-232, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34596779
ABSTRACT

AIM:

To report on glycated haemoglobin (HbA1c) values among individuals with normal glucose tolerance (NGT) at different age groups, using data acquired from a large national survey in India. MATERIALS AND

METHODS:

Data on glycaemic parameters at different age groups were obtained from the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study, in adults aged ≥ 20 years representing all parts of India. Age-wise distribution of HbA1c was assessed among individuals with NGT (n = 14,222) confirmed by an oral glucose tolerance test using the World Health Organization (WHO) criteria. Results were validated in another large epidemiological study (n = 1077) conducted in Chennai, India.

RESULTS:

Among NGT individuals, HbA1c increased gradually with age from 5.16 ± 0.71% (33 mmol/mol) in the age group of 20-29 years to 5.49 ± 0.69% (37 mmol/mol) in those aged 70 + years. In the validation study, conducted in another study population, HbA1c was 5.35 ± 0.43% (35 mmol/mol) in age group of 20-29 years and 5.74 ± 0.50% (39 mmol/mol) in those aged 70 and above. In the INDIAB study, for every decadal increase in age, there is a 0.08% increase in HbA1c and this increase was more significant in females (females 0.10% vs. males 0.06%) and in urban (urban 0.10% vs. rural 0.08%) population.

CONCLUSIONS:

HbA1c levels increase steadily with age. This suggests that age-specific cutoffs be used while utilizing HbA1c to diagnose diabetes and prediabetes, so as to minimize the risk of overdiagnosis and unnecessary initiation of treatment in elderly people who could have physiological increase in HbA1c levels.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Diabetes Mellitus País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Diabetes Mellitus País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia